X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2137) 2137
Publication (93) 93
Book Review (4) 4
Dissertation (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
Journal / eJournal (1) 1
Magazine Article (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1518) 1518
female (1438) 1438
gonadotropin-releasing hormone - analogs & derivatives (857) 857
adult (720) 720
male (680) 680
triptorelin pamoate - therapeutic use (569) 569
animals (514) 514
triptorelin pamoate - administration & dosage (494) 494
triptorelin pamoate - analogs & derivatives (475) 475
index medicus (453) 453
obstetrics & gynecology (438) 438
gonadotropin-releasing hormone - agonists (424) 424
pregnancy (404) 404
triptorelin pamoate (397) 397
gonadotropin-releasing hormone - therapeutic use (382) 382
luteinizing hormone - blood (364) 364
reproductive biology (364) 364
triptorelin pamoate - pharmacology (345) 345
gonadotropin-releasing hormone - pharmacology (335) 335
endocrinology & metabolism (308) 308
estradiol - blood (291) 291
triptorelin (284) 284
follicle stimulating hormone - blood (266) 266
middle aged (265) 265
gonadotropin-releasing hormone - administration & dosage (264) 264
child (216) 216
time factors (214) 214
puberty, precocious - drug therapy (213) 213
fertilization in vitro (212) 212
testosterone - blood (207) 207
delayed-action preparations (204) 204
treatment outcome (197) 197
gnrh agonist (192) 192
prostatic neoplasms - drug therapy (179) 179
ovulation induction - methods (178) 178
prospective studies (171) 171
gonadotropin-releasing hormone - antagonists & inhibitors (170) 170
rats (170) 170
aged (163) 163
triptorelin pamoate - adverse effects (157) 157
luteinizing-hormone (149) 149
ovulation induction (142) 142
women (142) 142
veterinary sciences (137) 137
antineoplastic agents, hormonal - therapeutic use (133) 133
ovary - drug effects (132) 132
hormones (131) 131
oncology (131) 131
progesterone - blood (130) 130
pregnancy rate (126) 126
drug implants (125) 125
agonist (124) 124
in-vitro fertilization (120) 120
embryo transfer (116) 116
adolescent (115) 115
luteolytic agents - therapeutic use (114) 114
gonadotropin-releasing-hormone (113) 113
therapy (109) 109
testosterone (106) 106
drug therapy, combination (104) 104
child, preschool (103) 103
retrospective studies (103) 103
follow-up studies (98) 98
ivf (94) 94
luteolytic agents - administration & dosage (92) 92
pituitary hormones (92) 92
endometriosis - drug therapy (90) 90
prostate cancer (88) 88
dose-response relationship, drug (87) 87
ovarian stimulation (87) 87
injections, intramuscular (85) 85
invitro fertilization (85) 85
drug administration schedule (82) 82
suppression (82) 82
ultrasonography (82) 82
gnrh (80) 80
gonadotropin-releasing hormone - adverse effects (80) 80
ovulation (80) 80
antineoplastic agents - therapeutic use (77) 77
pediatrics (77) 77
urology & nephrology (76) 76
endometriosis (75) 75
breast neoplasms - drug therapy (74) 74
pregnancy outcome (74) 74
chemotherapy (73) 73
deslorelin (73) 73
follicle-stimulating-hormone (73) 73
cancer (72) 72
fertilization in vitro - methods (72) 72
precocious puberty (72) 72
antineoplastic agents, hormonal - administration & dosage (70) 70
growth (70) 70
neurohormones (70) 70
testis - drug effects (70) 70
analysis (69) 69
antineoplastic combined chemotherapy protocols - therapeutic use (68) 68
obstetrics and gynecology (68) 68
secretion (68) 68
pituitary gland - drug effects (67) 67
progesterone (67) 67
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1916) 1916
French (73) 73
German (49) 49
Italian (25) 25
Spanish (20) 20
Chinese (17) 17
Czech (15) 15
Russian (11) 11
Polish (7) 7
Bulgarian (5) 5
Japanese (4) 4
Dutch (3) 3
Slovak (2) 2
Turkish (2) 2
Hungarian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 2, pp. 107 - 118
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2018, Volume 36, Issue 19, pp. 1981 - 1990
PurposeThe role of temporary ovarian suppression with gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy as a strategy to preserve ovarian... 
PROTECTION | ONCOLOGY | GNRH AGONIST | OUTCOMES | SUPPRESSION | YOUNG-WOMEN | TRIPTORELIN | PREGNANCY | Review
Journal Article
Journal of Pediatric Endocrinology and Metabolism, ISSN 0334-018X, 11/2016, Volume 29, Issue 11, pp. 1241 - 1248
Background: Triptorelin is an established treatment for central precocious puberty (CPP) as 1- and 3-month formulations. The current triptorelin 22.5 mg... 
triptorelin | 6-month formulation | central precocious puberty | efficacy and safety | TERM TREATMENT | ANALOG | FINAL HEIGHT | 11.25 MG | DEPOT | STIMULATION TEST | LEUPROLIDE ACETATE | LUTEINIZING-HORMONE | CHILDREN | GROWTH | ENDOCRINOLOGY & METABOLISM | PEDIATRICS | Estradiol - blood | United States | Humans | Follicle Stimulating Hormone, Human - antagonists & inhibitors | Child, Preschool | Male | Reproductive Control Agents - adverse effects | Triptorelin Pamoate - administration & dosage | Luteinizing Hormone - metabolism | Reproductive Control Agents - therapeutic use | Puberty, Precocious - drug therapy | Delayed-Action Preparations - administration & dosage | Testosterone - metabolism | Follicle Stimulating Hormone, Human - metabolism | Luteinizing Hormone - antagonists & inhibitors | Reproductive Control Agents - administration & dosage | Female | Child Development - drug effects | Testosterone - blood | Chile | Child | Gonadotropin-Releasing Hormone - agonists | Puberty, Precocious - metabolism | Estradiol - metabolism | Drug Administration Schedule | Luteinizing Hormone - blood | Osteogenesis - drug effects | Triptorelin Pamoate - adverse effects | Biomarkers - blood | Follicle Stimulating Hormone, Human - blood | Triptorelin Pamoate - therapeutic use | Estradiol - chemistry | Delayed-Action Preparations - adverse effects | Testosterone - antagonists & inhibitors | Delayed-Action Preparations - therapeutic use | Mexico | Puberty, Precocious - blood | Care and treatment | Precocious puberty
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 02/2013, Volume 165, Issue 3, pp. 199 - 206
Journal Article
JAMA, ISSN 0098-7484, 12/2015, Volume 314, Issue 24, pp. 2632 - 2640
Journal Article
Journal Article
Advances in Therapy, ISSN 0741-238X, 7/2016, Volume 33, Issue 7, pp. 1072 - 1093
Journal Article
Journal Article